Ready for a milk shake?

International Archives of Allergy and Immunology

Volumn 164, Issue 3, 2014, Pages 167-168

  Hochwallner, Heidrun ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; FOOD ALLERGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4;

ARTICLE; DERMATOPHAGOIDES; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MILK ALLERGY; SUBLINGUAL IMMUNOTHERAPY; T LYMPHOCYTE; ANIMAL; DESENSITIZATION; FEMALE; IMMUNOLOGY; MALE; PROCEDURES;

ANIMALS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MILK HYPERSENSITIVITY;

EID: 84903861641     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000365215     Document Type: Article

References (9)

1. Niedoszytko M, Bruinenberg M, de Monchy J, Wijmenga C, Platteel M, Jassem E, Oude Elberink JN: Gene expression analysis in predicting the effectiveness of insect venom immunotherapy. J Allergy Clin Immunol 2010; 125: 1092-1097.
2. Bousquet J, Hejjaoui A, Clauzel AM, Guerin B, Dhivert H, Skassa-Brociek W, Michel FB: Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988; 82: 971-977.
3. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T cell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120: 707-713.
4. OHehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, Rolland JM, Sandrini A: House dust mite sublingual immunotherapy: the role for transforming growth factor beta and functional regulatory T cells. Am J Respir Crit Care Med 2009; 180: 936-947.
5. Till S: Mechanisms of immunotherapy and surrogate markers. Allergy 2011; 66(suppl 95):25-27.
6. Savilahti EM, Kuitunen M, Savilahti E, Mäkelä MJ: Specific antibodies in oral immunotherapy for cows milk allergy: kinetics and prediction of clinical outcome. Int Arch Allergy Immunol 2014; 164: 32-39.
7. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, Nelson M, Weber R, Bernstein DI, Blessing-Moore J, Khan DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles S, Wallace D: Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011; 127:S1-S55.
8. Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ: Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008; 121: 1120-1125.
9. Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM, Bublin M, Curin M, Flicker S, Garmatiuk T, Hochwallner H, Mittermann I, Pahr S, Resch Y, Roux KH, Srinivasan B, Stentzel S, Vrtala S, Willison LN, Wickman M, Lodrup-Carlsen KC, Anto JM, Bousquet J, Bachert C, Ebner D, Schlederer T, Harwanegg C, Valenta R: Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods 2014; 66: 106-119.